At-home STD tests and newly approved treatments are expanding options for screening, privacy and care as U.S. infection rates decline.
Pap smears and HPV tests can catch issues early—long before they become cancer. Learn why these simple screenings matter and how to make the experience more comfortable.
The U.S. FDA’s Center for Biologics Evaluation and Research posted four warning letters to makers of HIV sample collection kits, an example of a shift in FDA enforcement in the IVD space that is still ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
NEW YORK — The US Food and Drug Administration has issued warning letters to four direct-to-consumer health testing companies for selling unauthorized blood collection kits for HIV diagnosis.
After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing. To say the science has come a long way is an understatement. With no treatments available ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope will keep downward pressure on U.S. infection rates. Last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results